Skip to Main Content
Insider Trading

Last Updated: 1 week ago

Steve Miller has an estimated net worth of at least $23.7 million*, as of Nov. 20, 2024. They own shares of CPRX stock. They have sold 588,896 shares of CPRX stock since 2021, for an estimated $9.3 million.

Steve Miller $CPRX SEC Form 4 Insider Trading

Steve Miller has filed a total of 12 insider trades in $CPRX since 2021. Their most recent trade was a sale of 50,000 shares, made on Aug 20, 2024. Their largest trade was a sale of 118,575 shares, made on Aug 18, 2022. We estimate that they now own shares of $CPRX, worth an estimated $14.4 million.



Insider Trading at $CPRX

There have been a total of 102 insider trades reported at $CPRX since 2021, with 0 shares purchased and 5.9 million shares sold. The most active insider traders in $CPRX stock have been Alicia Grande, Patrick J Mcenany, and Carmen Jeffrey Del. The most recent trade was a sale of 38,000 shares reported by GARY INGENITO (Chief Med. & Reg. Officer), made on Nov 20, 2024.



History of Insider Stock Trades by Steve Miller

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
CPRX Sale 50,000 Aug 20, 2024 Aug. 22, 2024, 5 p.m.
CPRX Sale 50,000 Aug 20, 2024 Aug. 22, 2024, 5 p.m.
CPRX Sale 50,000 Aug 20, 2024 Aug. 22, 2024, 5 p.m.
CPRX Sale 40,000 Dec 05, 2023 Dec. 7, 2023, 6 p.m.
CPRX Sale 80,000 Nov 21, 2022 Nov. 23, 2022, 6:01 p.m.
CPRX Sale 20,000 Nov 23, 2022 Nov. 23, 2022, 6:01 p.m.
CPRX Sale 25,000 Sep 13, 2022 Sept. 15, 2022, 5:01 p.m.
CPRX Sale 75,000 Sep 13, 2022 Sept. 15, 2022, 5:01 p.m.
CPRX Sale 7,933 Sep 13, 2022 Sept. 15, 2022, 5:01 p.m.
CPRX Sale 118,575 Aug 18, 2022 Aug. 19, 2022, 5:03 p.m.
CPRX Sale 31,425 Aug 18, 2022 Aug. 19, 2022, 5:03 p.m.
CPRX Sale 40,963 Aug 13, 2021 Aug. 16, 2021, 8 p.m.




$CPRX Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.